These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31888240)

  • 61. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
    Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
    J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy.
    Ma N; Wang Z; Zhao J; Long J; Xu J; Ren Z; Jiang G
    Med Sci Monit; 2017 May; 23():2315-2323. PubMed ID: 28512284
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
    Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
    Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genotyping the
    Liang KH; Yang PC; Yeh CT
    Oncol Lett; 2014 Nov; 8(5):2215-2220. PubMed ID: 25295111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
    Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
    Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers.
    Lin WR; Yeh CT
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098271
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma.
    Xi Q; Ma J
    J Oncol; 2023; 2023():1083423. PubMed ID: 38024474
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peridural Anesthesia and Cancer-Related Survival after Surgery for Pancreatic Cancer-A Retrospective Cohort Study.
    Alexander A; Lehwald-Tywuschik N; Rehders A; Rabenalt S; Verde PE; Eisenberger CF; Picker N; Knoefel WT; Kienbaum P
    Clin Pract; 2021 Aug; 11(3):532-542. PubMed ID: 34449573
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer.
    Grimminger PP; Stöhlmacher J; Vallböhmer D; Schneider PM; Hölscher AH; Metzger R; Danenberg PV; Brabender J
    J Oncol; 2009; 2009():139590. PubMed ID: 20016751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.
    Zuo T; Shan J; Liu Y; Xie R; Yu X; Wu C
    Transl Oncol; 2018 Apr; 11(2):346-352. PubMed ID: 29428518
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Kwon OS; Lee H; Kong HJ; Kwon EJ; Park JE; Lee W; Kang S; Kim M; Kim W; Cha HJ
    Oncogene; 2021 Mar; 40(10):1921. PubMed ID: 33574481
    [No Abstract]   [Full Text] [Related]  

  • 78. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Kwon OS; Lee H; Kong HJ; Kwon EJ; Park JE; Lee W; Kang S; Kim M; Kim W; Cha HJ
    Oncogene; 2020 Jun; 39(23):4567-4580. PubMed ID: 32388539
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Chu YD; Liu HF; Chen YC; Chou CH; Yeh CT
    Front Oncol; 2022; 12():996820. PubMed ID: 36530994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.